Drug Shortage Report for TEVA-OLANZAPINE

Last updated on 2020-10-15 History
Report ID 126527
Drug Identification Number 02359707
Brand name TEVA-OLANZAPINE
Common or Proper name OLANZAPINE 20MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-14
Estimated end date 2020-11-30
Actual end date
Shortage status Actual shortage
Updated date 2020-10-15
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-10-15 French Compare
v1 2020-10-15 English Compare